Max Planck Society - eDoc Server

Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA.
Authors: Owczarczyk, K.; Passon, D.; Roehrs, T.; Jung, N.; Taubert, D.; Valet, G.; Rubbert, A.
Date of Publication (YYYY-MM-DD): 2007-09
Title of Journal: Zeitschrift fur Rheumatologie
Volume: 66
Issue / Number: Suppl. Suppl. 1
Start Page: 40
End Page: 40
Document Type: Article
ID: 328417.0